Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
05/2009
05/13/2009CN100487124C Adeno-associated virus mediating trigenic cell expression system
05/13/2009CN100487120C Improved production of isoprenoids
05/13/2009CN100487113C Liancheng white duck embryo fibroblast and culture method thereof
05/13/2009CN100487112C Method of separating cattle marrow mesenchyme stem cell
05/13/2009CN100487111C A cultivation medium for test-tube seedling of detoxified potato and method for preparing the same
05/13/2009CN100486992C Tryptophanyl-tRNA synthetase derived polypeptides useful for the regulation of angiongenesis
05/12/2009US7531722 Soybean variety D4266582
05/12/2009US7531719 Soybean variety 4938051
05/12/2009US7531718 Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acids
05/12/2009US7531716 Materials and methods for producing tomato yellow leaf curl virus resistance in plants
05/12/2009US7531715 Method of reconstituting an animal embryo, the process comprising transferring a nucleus into a first oocyte followed by removing and transferring the nucleus from the oocyte to a further oocyte or to enucleated fertilized zygote; may be used to introduce genetic modifications into resultant offspring
05/12/2009US7531714 Non-human transgenic animals as model study for human pathologies, being transgenic for having altered melusin expression; the non-human transgenic animals are to be used to study heart pathologies and provide therapies thereof, wherein heart pathologies are heart failure, and diluted cardiomyopathy
05/12/2009US7531713 Assay for toxin induced neuronal degeneration and viability in C. elegans
05/12/2009US7531644 In which IL-6R and IL-6 are directly linked without a linker; blood platelet proliferating agent, ex vivo amplifier for hematopoietic stem cells
05/12/2009US7531642 Immunoglobulin specific for lymphadenopathy associated viral epitopes p24 and p26 for use as disgnostic tool in detection of viral disease
05/12/2009US7531641 Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26)
05/12/2009US7531640 Immunoglobulin specific for lymphadenopathy associated viral epitopes p24 and p26 for use as disgnostic tool in detection of viral disease
05/12/2009US7531639 Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26)
05/12/2009US7531638 Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26)
05/12/2009US7531637 Produced by hybridomas; antipruritic agents; blocks scratching, dermatitis, or hairloss
05/12/2009US7531636 A proinflammatory cytokine; monoclonal antibodies, or mixture of polyclonal antibodies; blocks signal transduction; hematopoietic cell proliferation
05/12/2009US7531635 Monoclonal antibodies or functional fragment; immunoassay kit; female fertility diagnosis; Premature ovarian failure
05/12/2009US7531628 Canine CD20 compositions
05/12/2009US7531626 Tenebrio antifreeze proteins
05/12/2009US7531625 Nucleotide sequences coding neuronal outgrowth and stability protein for use in treating ovarian, renal, neurological, cell proliferative and cardiovascular disorders
05/12/2009US7531524 For host undergoing surgery or coronary artery bypass
05/12/2009US7531523 Recombinant nucleic acid encoding a human sodium channel NaV1.3 polypeptide; diagnostic kit for detecting a nucleic acid that encodes the polypeptide
05/12/2009US7531356 exposing host cells in vitro that comprising genetic vector consisting a polynucleotide and a heterologous reporter gene operably linked to the polynucleotide, to test agents, then measuring and comparing the reporter gene expression level to that of a control cell that is not exposed to the test agent
05/12/2009US7531355 inducing leiomyogenic differentiation of a purified adipose-derived stem cells (ADSC), by contacting the cells in vitro with heparin, laminin or cell growth factors; grafting the ADSC's into tissues selected from the bladder or urethra
05/12/2009US7531354 comprising a serum-free cell differentiation medium consisting of fibroblast growth factor, non-essential amino acids, leukaemia inhibitory factors, an antibiotic, mercaptoethanol, nutrients or mixtures; drugs used for treating neurodegenerative diseases and cells used in bioassays
05/12/2009US7531353 Non self-inactivating, expression targeted retroviral vectors
05/12/2009US7531352 Inducible plasmid vector encoding TGF-β and use thereof
05/12/2009US7531347 Methods and compositions for synthesis of long chain polyunsaturated fatty acids
05/12/2009US7531339 Glyphosate-N-acetyltransferase (GAT) genes
05/12/2009US7531336 Methods for producing recombinant histidine-tagged inosine nonophosphate dehydrogenase polypeptides
05/12/2009US7531331 Butynol I esterase
05/12/2009US7531327 comprising a clonal population of host cells modified with a first nucleotide sequence integrated in the chromosomal DNA encoding a heterologous Bcl protein that inhibits apoptosis and with a second nucleotide sequence encoding a recombinant protein, in a medium suitable for cell growth
05/12/2009US7531326 Chimeric retinoid X receptors and their use in a novel ecdysone receptor-based inducible gene expression system
05/12/2009US7531321 Fibroblast growth factor-like molecules and uses thereof
05/12/2009US7531320 Modulation of β-catenin/TCF-activated transcription
05/12/2009US7531317 Fluorescence polarization assay to detect protease cleavage
05/12/2009US7531313 Screening for agents that modulate relaxin function
05/12/2009US7531311 determining the amount of a polynucleotide sequence or a fragment of at least 20 consecutive nucleotides in a test sample and comparing the amount with that from a control, wherein an increase indicates a gastrointestinal disorder
05/12/2009US7531304 Method for screening FGFR-4 agonists
05/12/2009US7531299 Using sperm adhesion molecule 1 (SPAM 1) as tool to enhance sperm attachment to egg; in vitro fertilization
05/12/2009US7531180 Chimeric alphavirus replicon particles
05/12/2009US7531177 Surface protein of leptospira
05/12/2009US7531175 Methods for modulation of immune responses using humanized immunoglobulins reactive with B7-1 molecules
05/12/2009US7531174 for in vitro diagnostics/antitumor agents; gene overexpression of cell surface proteins; genetic engineering;
05/12/2009US7531169 or an antigen binding fragment comprising variable light chain region and heavy chain peptides, directed against isotypic determinants of immunoglobulin E (IgE), useful for diagnostics, prophylaxis and treatment of disease such as asthma, rhinitis, eczema, urticaria. dermatitis or food allergies
05/12/2009US7530197 Automated system and method for harvesting and multi-stage screening of plant embryos
05/12/2009CA2415749C Method of producing infectious reovirus
05/12/2009CA2213254C Methods and compositions for gene therapy for the treatment of defects in lipoprotein metabolism
05/12/2009CA2201940C Method of treating diabetes mellitus using kgf
05/07/2009WO2009059287A2 Generation of biological pacemaker activity
05/07/2009WO2009059233A2 Near-infrared electromagnetic modification of cellular steady-state membrane potentials
05/07/2009WO2009059139A1 Assay of nitric oxide metabolites in the culture media of human preimplantation embryos
05/07/2009WO2009059115A1 Culture based screening assay and methods of use thereof to identify agents which modulate tumor development, invasion and differentiation
05/07/2009WO2009059032A2 Uses and isolation of very small embryonic-like (vsel) stem cells
05/07/2009WO2009058983A2 Subpopulations of bone marrow-derived adherent stem cells and methods of use therefor
05/07/2009WO2009058876A1 Method for a rapid antibody-based analysis of platelet populations
05/07/2009WO2009058451A2 Neuronal progenitor cells and methods of derivation and purification of neuronal progenitor cells from embryonic stem cells
05/07/2009WO2009058365A1 Methods for co-culturing cord blood derived cells with menstrual stem cells
05/07/2009WO2009058327A1 Cyclodextrin derivatives as potentiators for antibiotics
05/07/2009WO2009058326A1 Uses of a glycoprotein vi (gpvi) inhibitor
05/07/2009WO2009057831A1 Nuclear reprogramming method
05/07/2009WO2009057813A1 Method for high-level secretion and production of protein
05/07/2009WO2009057664A1 Antibody and use thereof
05/07/2009WO2009057537A1 Pharmaceutical composition containing human mesenchymal stem cell
05/07/2009WO2009057313A1 Method for induction of proliferation/differentiation of endothelial progenitor cell (epc)
05/07/2009WO2009057165A1 Use of microvesicles (mvs) derived from stem cells for preparing a medicament for endo/epithelial regeneration of damaged or injured tissues or organs, and related in vitro and in vivo methods
05/07/2009WO2009057061A1 Transgenic plants and modulators for improved stress tolerance
05/07/2009WO2009056580A1 Rabbit monoclonal antibody (mab cv152) anti-indoleamine 2 3-dioxygenase (ido)
05/07/2009WO2009056490A1 NEW ANTIBODIES SPECIFIC OF THE β-AMYLOID PEPTIDES AND THEIR USES AS DIAGNOSTIC AGENTS OR DRUGS
05/07/2009WO2009055868A1 Process and compositions for culturing cells
05/07/2009WO2009038417A3 Plant stem cell line derived from cambium of herbaceous plant with storage root and method for isolating the same
05/07/2009WO2009038416A3 Plant stem cell line derived from quiescent center and method for isolating the same
05/07/2009WO2009031831A3 The new parameter for x- and y- chromosome bearing sperm sorting with high degree of purity
05/07/2009WO2009023566A3 Method of treating autoimmune disease with mesenchymal stem cells
05/07/2009WO2009023562A3 Use of perfusion to enhance production of fed-batch cell culture in bioreactors
05/07/2009WO2009020645A3 Matriptase protein and uses thereof
05/07/2009WO2009018587A3 Derivation of neural stem cells from embryonic stem cells and methods of use thereof
05/07/2009WO2009012357A3 Methods to identify and enrich for populations of ovarian cancer stem cells and somatic ovarian stem cells and uses thereof
05/07/2009WO2008148563A3 Viral latency model
05/07/2009WO2008054767A3 N4 modifications of pyrimidine analogs and uses thereof
05/07/2009WO2008054716A3 Methods for identifying, isolating, and utilizing endocrine progenitor cells from adult human pancreata
05/07/2009WO2008026198A3 Methods of generating glial and neuronal cells and use of same for the treatment of medical conditions of the cns
05/07/2009WO2007136988A3 Compounds and methods for modulating expression of gccr
05/07/2009WO2007106571A3 Methods of screening for and mapping phenotypic and genotypic variations in cells
05/07/2009WO2007084678A3 Human liver cell line
05/07/2009WO2007059297A3 Multimeric biosensors and methods of using the same
05/07/2009WO2007059084A3 Methods for preparing cord matrix stem cells (cmsc) for long term storage and for preparing a segment of umbilical cord for cryopreservation
05/07/2009WO2007041218A3 Regulation of tool-like receptors on stem cells
05/07/2009WO2007033291A3 Regulatory cd8+t cells induced with anti-cd3 antibody
05/07/2009WO2007028101A3 Osteogenic and anti-adiogenic oxysterols
05/07/2009WO2007014162A3 Multiple gene expression including sorf constructs and methods with polyproteins, pro-proteins, and proteolysis
05/07/2009WO2007001430A3 Disimmortalizable mammalian chromaffin cell lines for cell therapy for pain
05/07/2009WO2006133098A3 Pharmacological chaperones for treating obesity
05/07/2009WO2006105254A3 Light as a replacement for mitrogenic factors on progenitor cells
05/07/2009WO2006073587A3 Hemipteran 5-hydroxytryptamine 7 serotonin receptor